...Silence Therapeutics plc (LSE:SLN) named Torsten Hoffmann COO. He was CSO and managing director at Proteros biostructures GmbH...

...Proteros and Merck partnered to develop small molecules against an epigenetic target to treat cancer. Proteros...
...details. Last October, the companies partnered to develop small molecules against a separate epigenetic target. Proteros biostructures GmbH...
...Martinsried, Germany Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Cancer Jaime De Leon Merck & Co. Inc. Proteros biostructures GmbH epigenetics...

...focus: Neurology Clinical status: Preclinical Founded: 2013 by Marty Jefson, Ankit Mahadevia, Atlas Venture and Proteros biostructures GmbH...

...of legal at Actavis plc , now known as Allergan plc (NYSE:AGN). Structural biology company Proteros biostructures GmbH...

...Rodin in 2013 with an undisclosed seed round and a partnership with fellow founding investor Proteros biostructures GmbH...
...Rodin CSO Martin Jefson told BioCentury the seed round enabled the biotech to work with Proteros'...

...notable deals include GlaxoSmithKline plc taking out Cellzome AG and Rodin Therapeutics Inc.'s partnership with Proteros biostructures GmbH...
...with Proteros, J&J's Janssen Research & Development LLC unit and the pharma's Boston Innovation Center; Proteros...
...chemical optimization Rodin has undisclosed financing from Atlas Venture and Johnson & Johnson Development Corp.; Proteros...

...very much at the heart of what we're doing," said Booth. Rodin is partnered with Proteros biostructures GmbH...
...Mentioned Atlas Venture , Cambridge, Mass. Centre National de la Recherche Scientifique , Strasbourg, France Proteros biostructures GmbH...

...small molecule epigenetic modulators to treat CNS disorders, including Alzheimer's disease (AD). Founding Rodin shareholder Proteros biostructures GmbH...
...N.Y. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts Institute of Technology (MIT), Cambridge, Mass. Proteros biostructures GmbH...

...including Alzheimer's disease (AD). Founding shareholder Proteros granted Rodin access to Proteros' structural biology platform. Proteros...
...centers are in London and California (see BioCentury Sept. 24, 2012 & June 10, 2013). Proteros biostructures GmbH...